Clinical trial set to test two drugs for fast-growing Ebola outbreak - Takeaways - MDSpire

Clinical trial set to test two drugs for fast-growing Ebola outbreak

Share

1

A clinical trial will test Gilead's remdesivir and MappBio's MBP-134 against the Bundibugyo ebolavirus in the Democratic Republic of the Congo.
2

The trial aims to determine the effectiveness of the therapies individually and in combination during the current Ebola outbreak.
3

The outbreak in the DRC is the third largest on record, with nearly 1,100 confirmed cases and over 275 deaths reported.
4

The U.S. government has supplied doses of MBP-134 for the trial, while Gilead has provided doses of remdesivir.
5

The trial will require approximately 1,000 participants due to the lower case fatality rate associated with the Bundibugyo species of Ebola.